Chingwei V. Lee

2.7k total citations
20 papers, 1.7k citations indexed

About

Chingwei V. Lee is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Chingwei V. Lee has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Chingwei V. Lee's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (8 papers) and Angiogenesis and VEGF in Cancer (4 papers). Chingwei V. Lee is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (8 papers) and Angiogenesis and VEGF in Cancer (4 papers). Chingwei V. Lee collaborates with scholars based in United States, France and Poland. Chingwei V. Lee's co-authors include Germaine Fuh, Wei‐Ching Liang, Franklin Peale, Sachdev S. Sidhu, Christian Wiesmann, Xiumin Wu, Napoleone Ferrara, Jenny Boström, Y. Gloria Meng and Johnny Gutierrez and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Chingwei V. Lee

20 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chingwei V. Lee United States 16 1.2k 878 478 312 207 20 1.7k
Francesca Viti Italy 19 1.2k 1.0× 1.2k 1.4× 433 0.9× 344 1.1× 179 0.9× 33 2.0k
Wei‐Ching Liang United States 17 1.4k 1.2× 462 0.5× 622 1.3× 295 0.9× 322 1.6× 31 2.0k
Marina Cardó‐Vila United States 25 1.0k 0.8× 431 0.5× 376 0.8× 345 1.1× 243 1.2× 31 1.7k
Raluca Verona United States 26 2.0k 1.6× 392 0.4× 1.5k 3.0× 513 1.6× 224 1.1× 61 3.2k
Eugen Leo Germany 15 748 0.6× 452 0.5× 783 1.6× 705 2.3× 310 1.5× 42 1.9k
Helen Kalirai United Kingdom 25 847 0.7× 256 0.3× 613 1.3× 509 1.6× 221 1.1× 89 1.8k
Grit Zahn Germany 23 744 0.6× 709 0.8× 473 1.0× 162 0.5× 153 0.7× 47 1.7k
Nicole C. Naus Netherlands 23 562 0.5× 240 0.3× 543 1.1× 355 1.1× 173 0.8× 59 1.5k
Jean-Michel Vernes United States 12 613 0.5× 365 0.4× 552 1.2× 462 1.5× 192 0.9× 15 1.3k
Malin Pedersen United Kingdom 22 1.3k 1.0× 126 0.1× 1.1k 2.2× 673 2.2× 293 1.4× 37 2.4k

Countries citing papers authored by Chingwei V. Lee

Since Specialization
Citations

This map shows the geographic impact of Chingwei V. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chingwei V. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chingwei V. Lee more than expected).

Fields of papers citing papers by Chingwei V. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chingwei V. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chingwei V. Lee. The network helps show where Chingwei V. Lee may publish in the future.

Co-authorship network of co-authors of Chingwei V. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chingwei V. Lee. A scholar is included among the top collaborators of Chingwei V. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chingwei V. Lee. Chingwei V. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Peiwen, Emon Elboudwarej, Marianna Zavodovskaya, et al.. (2025). Trop-2 expression in non–small cell lung cancer. PLoS ONE. 20(4). e0321555–e0321555. 2 indexed citations
2.
Tom, Irene, Victoria C. Pham, Kenneth J. Katschke, et al.. (2020). Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy. Proceedings of the National Academy of Sciences. 117(18). 9952–9963. 40 indexed citations
3.
Thackaberry, Evan A., Yi Zhou, Christina L. Zuch de Zafra, et al.. (2019). Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor Outflow. Investigative Ophthalmology & Visual Science. 60(13). 4097–4097. 11 indexed citations
4.
Koenig, Patrick, Sarah Sanowar, Chingwei V. Lee, & Germaine Fuh. (2017). Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanning. mAbs. 9(6). 959–967. 14 indexed citations
5.
Koenig, Patrick, Chingwei V. Lee, Benjamin T. Walters, et al.. (2017). Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding. Proceedings of the National Academy of Sciences. 114(4). E486–E495. 68 indexed citations
6.
Koenig, Patrick, Chingwei V. Lee, Sarah Sanowar, et al.. (2015). Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration. Journal of Biological Chemistry. 290(36). 21773–21786. 41 indexed citations
7.
Gadkar, Kapil, Cinthia V. Pastuskovas, J. Michael Elliott, et al.. (2015). Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics. Investigative Ophthalmology & Visual Science. 56(9). 5390–5390. 55 indexed citations
8.
Lee, Chingwei V., Patrick Koenig, & Germaine Fuh. (2014). A Two-in-One antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions. mAbs. 6(3). 622–627. 19 indexed citations
9.
Gogineni, Alvin, Maresa Caunt, Ailey Crow, et al.. (2013). Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis. PLoS ONE. 8(7). e68755–e68755. 62 indexed citations
10.
Kim, Hok Seon, James A. Ernst, Jenny Boström, et al.. (2012). Translation Levels Control Multi-Spanning Membrane Protein Expression. PLoS ONE. 7(4). e35844–e35844. 7 indexed citations
11.
Singh, Mallika, Rafael Molina, Vidusha Devasthali, et al.. (2010). Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. Nature Biotechnology. 28(6). 585–593. 175 indexed citations
12.
Boström, Jenny, Shang‐Fan Yu, David Kan, et al.. (2009). Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site. Science. 323(5921). 1610–1614. 263 indexed citations
13.
Boström, Jenny, Chingwei V. Lee, Lauric Haber, & Germaine Fuh. (2008). Improving Antibody Binding Affinity and Specificity for Therapeutic Development. Methods in molecular biology. 525. 353–376. 42 indexed citations
14.
Yu, Lanlan, Xiumin Wu, Zhiyong Cheng, et al.. (2008). Interaction between Bevacizumab and Murine VEGF-A: A Reassessment. Investigative Ophthalmology & Visual Science. 49(2). 522–522. 138 indexed citations
15.
Gerber, Hans‐Peter, Xiumin Wu, Lanlan Yu, et al.. (2007). Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proceedings of the National Academy of Sciences. 104(9). 3478–3483. 77 indexed citations
16.
Lee, Chingwei V., S.G. Hymowitz, Heidi J.A. Wallweber, et al.. (2006). Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood. 108(9). 3103–3111. 48 indexed citations
17.
Fuh, Germaine, Ping Wu, Wei‐Ching Liang, et al.. (2005). Structure-Function Studies of Two Synthetic Anti-vascular Endothelial Growth Factor Fabs and Comparison with the Avastin™ Fab. Journal of Biological Chemistry. 281(10). 6625–6631. 153 indexed citations
18.
Liang, Wei‐Ching, Xiumin Wu, Franklin Peale, et al.. (2005). Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF. Journal of Biological Chemistry. 281(2). 951–961. 282 indexed citations
19.
Lee, Chingwei V., Wei‐Ching Liang, Mark S. Dennis, et al.. (2004). High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold. Journal of Molecular Biology. 340(5). 1073–1093. 177 indexed citations
20.
Lee, Chingwei V., Sachdev S. Sidhu, & Germaine Fuh. (2003). Bivalent antibody phage display mimics natural immunoglobulin. Journal of Immunological Methods. 284(1-2). 119–132. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026